Dihydroartemisinin broke immune evasion through YAP1/JAK1/STAT1, 3 pathways to enhance anti-PD-1 therapy in hepatocellular carcinoma

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Epidemiology

Show all topics

DOI

10.1101/2021.11.30.470572

License

CC-BY

Other Formats

PDF